|Gardiquimod||Unit size||Cat. code||Docs||Qty||Price|
Imidazoquinoline compound | TLR7 Agonist
Gardiquimod™ is an imidazoquinoline compound developed and manufactured by InvivoGen. Similarly to Imiquimod, Gardiquimod™ induces the activation of NF-κB in HEK293 cells expressing human or mouse TLR7. Interestingly, Gardiquimod™ is more potent than Imiquimod. Gardiquimod™ is specific for TLR7 when used at less than 1 µg/ml.
Specificity: human/mouse TLR7 agonist
Working concentration: 0.1 - 3 µg/ml
CAS number: 1020412-43-4
Endotoxin level: EndoFit™ (<0.001 EU/μg)
Solubility: 1 mg/ml in waterBack to the top
• Gardiquimod™ is available in two quantities:
- 500 μg Gardiquimod™: tlrl-gdqs
- 5 mg Gardiquimod™: tlrl-gdq-5
• sterile endotoxin-free water, 1.5 ml with #tlrl-gdqs and 10 ml with #tlrl-gdq-5.
Gardiquimod™ is provided lyophilized and shipped at room temperature. Store at -20°C. Lyophilized product is stable for 1 year at -20°C when properly stored. Upon resuspension, prepare ailquots of Gardiquimod™ and store at -20°C for long term storage. Resuspended product is stable for 6 months at -20°C. Avoid repeated freeze-thaw cycles.Back to the top